title: Early versus delayed initiation of pharmacotherapy in Parkinson's disease.
abstract: Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's disease and pathologically is characterised by a progressive loss of dopaminergic cells of the nigrostriatal pathway. Clinically, PD is mainly defined by the presence of the motor symptoms of bradykinesia, rigidity, rest tremor and postural instability, but non-motor symptoms such as depression, dementia and autonomic disturbances are recognised as integral parts of the disease. Although pharmacotherapy for PD was introduced almost 50 years ago, and has improved significantly over the intervening period, the timing of initiation of treatment in newly diagnosed PD remains controversial. While some physicians favour an early start of pharmacotherapy at or soon after diagnosis, others prefer to delay pharmacological treatment until a certain degree of disability has developed. This article aims to discuss the advantages and disadvantages of both strategies by exploring their effects on symptoms, disease progression and quality of life. Although the data on putative disease-modifying effects of early pharmacological intervention in PD are still inconclusive, we believe that the most important indication for an early initiation of anti-parkinsonian treatment should be to maintain the quality of life of PD patients and to secure their socioeconomic status as long as possible.
authors.affiliation: Department of Neurology, Dresden University of Technology, Dresden, Germany.
authors.forename: Matthias
authors.initials: M
authors.lastname: Löhle
authors.forename: Carl-Johan
authors.initials: CJ
authors.lastname: Ramberg
authors.forename: Heinz
authors.initials: H
authors.lastname: Reichmann
authors.forename: Anthony H V
authors.initials: AH
authors.lastname: Schapira
mesh_terms: D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004185:Disability Evaluation; D018450:Disease Progression; D006801:Humans; D010300:Parkinson Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D011788:Quality of Life; D013997:Time Factors
chemical_list: D000978:Antiparkinson Agents
references.citation: Lancet Neurol. 2007 Jun;6(6):513-20
references.pmid: 17509486
references.citation: Lancet Neurol. 2006 Mar;5(3):235-45
references.pmid: 16488379
references.citation: Neurology. 1992 Feb;42(2):339-43
references.pmid: 1736162
references.citation: Eur J Neurol. 2011 Feb;18(2):201-202
references.pmid: 20602632
references.citation: J Neurol Neurosurg Psychiatry. 2008 Jun;79(6):716-8
references.pmid: 18223017
references.citation: Arch Neurol. 2002 Dec;59(12):1937-43
references.pmid: 12470183
references.citation: J Neurol. 2005 Oct;252 Suppl 4:IV37-IV42
references.pmid: 16222436
references.citation: Mov Disord. 2008 Apr 30;23(6):784-9
references.pmid: 18175348
references.citation: Eur J Neurol. 1999 Sep;6(5):539-47
references.pmid: 10457386
references.citation: Neurology. 1986 Nov;36(11):1528-30
references.pmid: 3762973
references.citation: Neurology. 2005 Nov 8;65(9):1436-41
references.pmid: 16275832
references.citation: Neurology. 2007 Apr 3;68(14):1108-15
references.pmid: 17404192
references.citation: Arch Neurol. 2004 Jul;61(7):1044-53
references.pmid: 15262734
references.citation: Neurology. 2006 May 23;66(10 Suppl 4):S80-8
references.pmid: 16717255
references.citation: Eur J Neurol. 2002 Jan;9(1):9-14
references.pmid: 11784369
references.citation: Eur J Neurol. 2011 Mar;18(3):448-53
references.pmid: 20722714
references.citation: Eur J Neurol. 2012 Jan;19(1):76-83
references.pmid: 21645174
references.citation: Eur J Neurol. 2012 Mar;19(3):494-500
references.pmid: 22040282
references.citation: J Neurol Neurosurg Psychiatry. 2007 May;78(5):465-9
references.pmid: 17098846
references.citation: N Engl J Med. 2004 Dec 9;351(24):2498-508
references.pmid: 15590952
references.citation: N Engl J Med. 1993 Jan 21;328(3):176-83
references.pmid: 8417384
references.citation: Arch Neurol. 2004 Apr;61(4):561-6
references.pmid: 15096406
references.citation: Mov Disord. 1998 Jan;13(1):39-45
references.pmid: 9452324
references.citation: Arch Neurol. 2006 Feb;63(2):205-9
references.pmid: 16476808
references.citation: Eur J Neurol. 2011 Mar;18 Suppl 1:3-10
references.pmid: 21255197
references.citation: Arch Neurol. 1993 Feb;50(2):140-8
references.pmid: 8431132
references.citation: Ann Neurol. 2010 Jul;68(1):18-27
references.pmid: 20582993
references.citation: BMC Neurol. 2011 Sep 22;11:112
references.pmid: 21939547
references.citation: Exp Neurol. 2008 Aug;212(2):255-7
references.pmid: 18571162
references.citation: Eur J Neurol. 2012 Dec;19(12):1575-81
references.pmid: 22747791
references.citation: Mov Disord. 1993;8 Suppl 1:S36-40
references.pmid: 8302306
references.citation: Ann Neurol. 2003 Jul;54(1):93-101
references.pmid: 12838524
references.citation: N Engl J Med. 2013 Feb 14;368(7):610-22
references.pmid: 23406026
references.citation: Lancet. 2009 Aug 15;374(9689):577-85
references.pmid: 19683643
references.citation: Mov Disord. 2006 Dec;21(12):2187-91
references.pmid: 17183549
references.citation: Neurology. 2006 May 23;66(10 Suppl 4):S58-68
references.pmid: 16717253
references.citation: Eur J Neurol. 2013 Jan;20(1):1-2
references.pmid: 22612423
references.citation: Eur J Neurol. 2013 Mar;20(3):480-485
references.pmid: 23078376
references.citation: Lancet Neurol. 2011 May;10(5):415-23
references.pmid: 21482191
references.citation: J Pharmacokinet Pharmacodyn. 2006 Jun;33(3):281-311
references.pmid: 16625427
references.citation: Eur J Neurol. 2011 Mar;18 Suppl 1:1-2
references.pmid: 21255196
references.citation: Neurology. 2011 Aug 23;77(8):767-74
references.pmid: 21832216
references.citation: Wien Klin Wochenschr. 1961 Nov 10;73:787-8
references.pmid: 13869404
references.citation: Ann Neurol. 1996 Jan;39(1):29-36
references.pmid: 8572663
references.citation: Mov Disord. 2000 Mar;15(2):212-5
references.pmid: 10752568
references.citation: Eur J Neurol. 2013 Jan;20(1):16-34
references.pmid: 23279440
references.citation: Eur J Neurol. 2011 Jul;18(7):980-7
references.pmid: 21199185
references.citation: Eur J Neurol. 2010 Feb;17(2):260-6
references.pmid: 20039939
references.citation: Mov Disord. 2004 Jan;19(1):22-8
references.pmid: 14743356
references.citation: Acta Neurol Scand. 1997 Apr;95(4):211-8
references.pmid: 9150811
references.citation: Drugs Aging. 2009;26(11):973-80
references.pmid: 19848442
references.citation: Science. 1989 Aug 4;245(4917):519-22
references.pmid: 2502843
references.citation: Eur J Neurol. 2010 Nov;17(11):1365-9
references.pmid: 20443985
references.citation: Eur Neuropsychopharmacol. 2011 Feb;21(2):180-91
references.pmid: 20888737
references.citation: Eur J Neurol. 2012 Dec;19(12):1483-6
references.pmid: 23157243
references.citation: Brain. 2000 Nov;123 ( Pt 11):2297-305
references.pmid: 11050029
references.citation: Mov Disord. 2013 Mar;28(3):319-26
references.pmid: 23404374
references.citation: N Engl J Med. 2000 May 18;342(20):1484-91
references.pmid: 10816186
references.citation: JAMA. 2002 Apr 3;287(13):1653-61
references.pmid: 11926889
references.citation: Curr Med Res Opin. 2008 Oct;24(10):2883-95
references.pmid: 18768106
references.citation: Mov Disord. 2011 Oct;26 Suppl 3:S2-41
references.pmid: 22021173
references.citation: Mov Disord. 2006 Aug;21(8):1200-7
references.pmid: 16673410
references.citation: Ann Neurol. 1987 Jul;22(1):8-12
references.pmid: 3631925
references.citation: Eur J Neurol. 2013 Oct;20(10):1398-404
references.pmid: 23679105
references.citation: Lancet Neurol. 2009 May;8(5):464-74
references.pmid: 19375664
references.citation: Neurology. 2007 Jan 23;68(4):272-6
references.pmid: 17202432
references.citation: Eur J Neurol. 2010 Sep;17(9):1156-1163
references.pmid: 20345926
references.citation: Eur J Neurol. 2012 Jan;19(1):105-13
references.pmid: 21699627
references.citation: Neurology. 2007 Jan 30;68(5):384-6
references.pmid: 17082464
references.citation: Ann Neurol. 2006 Mar;59(3):562-4; discussion 564-5
references.pmid: 16489613
references.citation: Brain. 1991 Oct;114 ( Pt 5):2283-301
references.pmid: 1933245
references.citation: J Neurochem. 2006 Mar;96(5):1315-21
references.pmid: 16464239
references.citation: Ann Neurol. 2013 May;73(5):565-75
references.pmid: 23483564
references.citation: N Engl J Med. 1989 Nov 16;321(20):1364-71
references.pmid: 2509910
references.citation: Eur J Neurol. 2013 Jan;20(1):50-6
references.pmid: 22537207
references.citation: Neurology. 2011 Aug 23;77(8):759-66
references.pmid: 21832218
references.citation: JAMA. 2000 Oct 18;284(15):1931-8
references.pmid: 11035889
references.citation: Eur J Neurol. 2012 Jul;19(7):963-8
references.pmid: 22340430
references.citation: Eur J Neurol. 2012 Feb;19(2):258-64
references.pmid: 21819487
references.citation: Lancet Neurol. 2010 Jun;9(6):573-80
references.pmid: 20452823
references.citation: Lancet Neurol. 2013 Aug;12(8):747-55
references.pmid: 23726851
references.citation: Eur J Neurol. 2009 Oct;16(10):1090-9
references.pmid: 19723294
references.citation: Ann Neurol. 2002 May;51(5):604-12
references.pmid: 12112107
references.citation: Acta Neurol Scand. 1995 Dec;92(6):455-63
references.pmid: 8750110
references.citation: Eur J Neurol. 2008 Apr;15 Suppl 1:5-13
references.pmid: 18353131
references.citation: Cochrane Database Syst Rev. 2009 Oct 07;(4):CD006661
references.pmid: 19821381
references.citation: Mov Disord. 2011 Jun;26(7):1259-65
references.pmid: 21469195
references.citation: Mov Disord. 2007 Dec;22(16):2398-404
references.pmid: 17935234
references.citation: BMJ. 2004 Sep 11;329(7466):593
references.pmid: 15310558
references.citation: Pharm Res. 2007 Apr;24(4):791-802
references.pmid: 17308968
references.citation: Semin Neurol. 2007 Apr;27(2):106-12
references.pmid: 17390255
references.citation: Arch Neurol. 2005 Mar;62(3):378-82
references.pmid: 15767502
references.citation: Ann Neurol. 1995 Nov;38(5):771-7
references.pmid: 7486869
references.citation: Nat Rev Neurol. 2011 May;7(5):247-8
references.pmid: 21423265
references.citation: Mov Disord. 2010 Oct 30;25(14):2326-32
references.pmid: 20669265
references.citation: Eur J Neurol. 2011 Mar;18(3):519-26
references.pmid: 20840378
references.citation: Mov Disord. 2009 Apr 30;24(6):826-32
references.pmid: 19191340
references.citation: Neurology. 1990 Feb;40(2):265-9
references.pmid: 2300246
references.citation: Mov Disord. 2010 Nov 15;25(15):2542-9
references.pmid: 20669317
references.citation: Ann Neurol. 2008 Dec;64 Suppl 2:S101-10
references.pmid: 19127580
references.citation: Parkinsonism Relat Disord. 2001 Apr;7(2):107-114
references.pmid: 11248591
references.citation: Neurology. 2008 Aug 12;71(7):474-80
references.pmid: 18579806
references.citation: Eur J Neurol. 2010 Apr;17(4):626-30
references.pmid: 20050904
references.citation: Eur J Neurol. 2012 Aug;19(8):1108-13
references.pmid: 22390275
references.citation: Parkinsonism Relat Disord. 2007 Sep;13 Suppl:S8-S12
references.pmid: 17702630
references.citation: Mov Disord. 2007 May 15;22(7):938-45
references.pmid: 17415791
references.citation: Arch Neurol. 2009 May;66(5):563-70
references.pmid: 19433655
references.citation: Eur J Neurol. 2011 Feb;18(2):286-292
references.pmid: 20602633
references.citation: Mov Disord. 2011 Jan;26(1):51-8
references.pmid: 21322019
references.citation: Trends Neurosci. 2000 Oct;23(10 Suppl):S117-26
references.pmid: 11052229
references.citation: Mov Disord. 2007 Mar 15;22(4):476-82
references.pmid: 17318839
references.citation: Eur J Neurol. 2012 Jul;19(7):931-2
references.pmid: 22340279
references.citation: Eur J Neurol. 2011 Mar;18 Suppl 1:11-5
references.pmid: 21255198
references.citation: Eur J Neurol. 2011 Feb;18(2):260-265
references.pmid: 20586791
references.citation: Exp Neurol. 2008 Aug;212(2):522-31
references.pmid: 18571649
references.citation: Neurology. 1998 Aug;51(2):520-5
references.pmid: 9710028
references.citation: Arch Neurol. 2002 Oct;59(10):1541-50
references.pmid: 12374491
references.citation: N Engl J Med. 2009 Sep 24;361(13):1268-78
references.pmid: 19776408
references.citation: Eur J Neurol. 2012 Dec;19(12):1502-8
references.pmid: 22221452
references.citation: Mov Disord. 2007 Dec;22(16):2409-17
references.pmid: 17894339
references.citation: Neurology. 1997 Sep;49(3):724-8
references.pmid: 9305331
references.citation: Mov Disord. 2011 Jun;26(7):1187-93
references.pmid: 21495068
references.citation: Eur J Neurol. 2012 Mar;19(3):510-6
references.pmid: 22040383
references.citation: Mov Disord. 2009 Mar 15;24(4):564-73
references.pmid: 19086083
references.citation: Eur J Neurol. 2013 Jan;20(1):5-15
references.pmid: 23279439
references.citation: J Neurochem. 2004 Dec;91(5):1075-81
references.pmid: 15569251
references.citation: Eur J Neurol. 2013 Jan;20(1):180-7
references.pmid: 22845710
references.citation: Neurology. 2001 Oct 23;57(8):1497-9
references.pmid: 11673599
references.citation: Ann Neurol. 2008 Dec;64 Suppl 2:S47-55
references.pmid: 19127579
references.citation: Mov Disord. 2013 Jul;28(8):1064-71
references.pmid: 23630119
references.citation: Arch Neurol. 2007 Aug;64(8):1083-8
references.pmid: 17698697
references.citation: Mov Disord. 2010 Aug 15;25(11):1627-32
references.pmid: 20544810
references.citation: Ann Neurol. 2006 Mar;59(3):559-62
references.pmid: 16489611
references.citation: Arch Neurol. 1999 Mar;56(3):334-7
references.pmid: 10190824